Continue to site >
Trending ETFs
Guide

/

Health Care

/

Medical Equipment & Devices

/

Medical Devices

Medical Devices Dividends Stocks, ETFs, Funds

As of 12/01/2021. Within the healthcare sector, medical equipment and device manufacturers... As of 12/01/2021. Within the healthcare sector, medical equipment and device manufacturers are major suppliers to hospitals and healthcare facilities. Companies in this industry manufacture and supply pharmaceuticals, medical tools, endoscopes, cameras, video sets, clinical testing systems and other products used by healthcare professionals. View more View less

As of 12/01/2021. Within the healthcare sector, medical equipment and device manufacturers are major suppliers to hospitals and healthcare facilities. Companies in this industry manufacture and supply pharmaceuticals, medical tools, endoscopes, cameras, video... As of 12/01/2021. Within the healthcare sector, medical equipment and device manufacturers are major suppliers to hospitals and healthcare facilities. Companies in this industry manufacture and supply pharmaceuticals, medical tools, endoscopes, cameras, video sets, clinical testing systems and other products used by healthcare professionals. View more View less

Overview

Payout

Income

Income Risk

Returns

Allocations

Fees

About

$105.93

+0.89%

-

5.19%

$5.50

blocked
blocked
blocked

-4.17%

-

Medtronic Plc

MDT | Stock

$105.47

-1.15%

$148.21 B

2.39%

$2.52

blocked
blocked
blocked

-8.91%

-

Abbott Laboratories

ABT | Stock

$126.74

+0.77%

$226.39 B

1.42%

$1.80

blocked
blocked
blocked

14.87%

-

$14.29

-4.48%

$2.65 B

1.17%

$0.17

blocked
blocked
blocked

-21.30%

-

Stryker Corp.

SYK | Stock

$239.10

+1.04%

$91.82 B

1.05%

$2.52

blocked
blocked
blocked

-3.43%

-

Lemaitre Vascular Inc

LMAT | Stock

$47.40

+1.30%

$1.04 B

0.93%

$0.44

blocked
blocked
blocked

15.53%

-

$108.08

+1.22%

-

0.29%

$0.31

blocked
blocked
blocked

76.20%

-

Get dividend stock picks, research and news in your inbox each week.

Our research team runs the industry’s toughest dividend screening test and only picks from the top 5%.